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Purpose
Chronic disorders, such as rheumatic disease, impact chil-
dren emotionally, socially and physically. Children who
perceive their medical condition interferes with the ability
to engage in social, educational and family activities report
more depressive symptoms. The purpose of this study is
to examine the prevalence of depression in children with
rheumatic disease and to identify concomitant risk factors
for depression in this population. It was hypothesized that,
compared to healthy peers, children with rheumatic dis-
eases may have a higher risk of developing depressive
symptoms.
Methods
Participants were children, 8-17 years old, followed by a
pediatric rheumatology practice and identified at a routine
follow-up appointment. Children completed the Child-
hood Depression Inventory (CDI) and parent-child pairs
completed a series of standardized measures documenting
demographics, symptoms, health-related quality of life,
coping mechanisms and psychosocial variables. The pri-
mary rheumatologist documented a global assessment of
disease severity as well as disease activity scores for chil-
dren with the diagnosis of juvenile idiopathic arthritis
(JIA), juvenile dermatomyositis (JDMS) or systemic lupus
erythematosus (SLE). One-way ANOVAs were completed
to determine if demographic variables were significantly
associated with depression. Pearson product moment cor-
relations were run to determine relationships between the
depression, pain, coping, quality of life, family conflict,
physical functioning and disease severity. Hierarchal multi-
ple regression analyses were run to determine which
medical and psychosocial variables were significant predic-
tors of depression in children with rheumatic disease,
while controlling for demographic variables.
Results
At this time, 96 patients have been screened (78% female)
and only data regarding demographics, length of diagno-
sis and physician documented disease activity has been
examined. Five percent of the population was found to
have clinically significant symptoms of depression while
15% of the population was found to be “at risk” for symp-
toms of depression. Seven percent of participants were
receiving medication for depression and an additional 7%
were involved in therapy at screening. Medication usage
significantly correlated with increased CDI scores
(increased depressive symptoms) whereas those in ther-
apy had CDI scores comparable to their non-depressed
peers. Total CDI score also significantly correlated with
female gender and an increased number of children in
the home. Neither years since diagnosis, active joint
count, total SLEDAI score, JDMS disease activity score
nor physician global assessment correlated with increased
CDI scores. Additional analyses of psychosocial factors
are in progress.
Conclusion
The prevalence and risk of depression among children
with rheumatic diseases is comparable to previously
reported data for a healthy population of children.
Female gender and number of siblings are associated
with increased risk of depressive symptoms. Early data
suggests that medications appear to be less efficacious at
controlling depressive symptoms than intervention with
therapy.
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